11/23/2005

NIH funds QB3 nanomedicine

By Wallace Ravven, UCSF News Office

A QB3-led collaboration among scientists at UC San Francisco, UC Berkeley, and Lawrence Berkeley National Laboratory has been awarded a five-year, $7 million NIH grant in the areas of synthetic biology and nanomedicine.

Part of the new NIH Nanomedicine initiative, the project aims to apply engineering approaches to understand the design principles of cellular control systems, focusing particularly on those systems that control cell movement. The long-range goal is to be able to precisely engineer therapeutically useful cells.

The research initiative, Engineering Cellular Control: Synthetic Signaling and Motility Systems, is part of the first major funding initiative in the NIH Nanomedicine program. Principal investigator is Wendell A. Lim, Ph.D., UCSF Professor of Cellular and Molecular Pharmacology and a QB3 faculty affiliate.

Related links

Wendell Lim's lab

UCSF/UCB Center for Engineering Cellular Control Systems